Specific screening tools

Using longitudinal data with physician-identified cases, we can compare and follow these cases against matched controls; furthermore, we are able to work our way back in time with retrospective data spanning 12 years to list early predictors of NASH and Alzheimer’s Disease.
The huge scope for data collected (several thousand data fields) including signs and symptoms typically collected during anamnesis, put us in the strongest position to use predictive analytics to create algorithms and tools that can be self administered to identify subjects at risk of early NASH and Alzheimer’s Disease.